Results 81 to 90 of about 1,084 (158)

Effectiveness and Safety of Reduced-Dose Prasugrel in an East Asian Population: PRASFIT-ACS Emulation Using National Health Insurance Claims Data. [PDF]

Clin Pharmacol Ther
Huang LW, Wu YJ, Lin FJ, Wu CC, Huang HY, Wang CC, Li X.   +6 more
europepmc   +1 more source

Flow diversion with hydrophilic polymer coating with prasugrel as single antiplatelet therapy in the treatment of acutely ruptured intracranial aneurysms: a multicenter case series, complication and occlusion rates. [PDF]

J Neurointerv Surg
Khanafer A, Lobsien D, Sirakov A, Almohammad M, Schüngel MS, Pielenz D, Borgmann T, Hajiyev K, Bäzner H, Ganslandt O, Hennersdorf F, Cohen JE, Felber S, Schob S, Kemmling A, Sirakov S, Forsting M, Klisch J, Henkes H.   +18 more
europepmc   +1 more source

Efficacy and safety of low-dose prasugrel as dual antiplatelet therapy in patients with ischemic heart disease: a systematic review and network meta-analysis of randomized controlled trials. [PDF]

Cardiovasc Interv Ther
Fujii T, Amano K, Kasai S, Kawamura Y, Yoshimachi F, Ikari Y.   +5 more
europepmc   +1 more source

Dissolution Rate Improvement of Prasugrel Hydrochloride by Solid Dispersion Method Using HPMC-AS as a Polymer

International Journal of Scientific Research and Reviews, 2019
Warkad S. S, Anantwar P. S, Bhusari M. R, Tale P. D, Pakhare V. S   +4 more
openaire   +1 more source

Antiplatelet therapy and central nervous system hematomas: a cohort study using real-world data from the FAERS and VigiAccess databases. [PDF]

Int J Surg
Wang L, Cai H, Zhao S.
europepmc   +1 more source

Optimal antiplatelet therapy in patients with acute coronary syndrome and chronic kidney disease: for the Jerusalem platelets thrombosis and intervention in cardiology (JUPITER-11) study group. [PDF]

BMC Nephrol
Nimrod P, David M, Louay T, Meir T, Amsalem I, Hitter R, Maller T, Levy N, Lupu L, Shmueli H, Bruoha S, Ovdat T, Glikson M, Asher E.   +13 more
europepmc   +1 more source

Comparative Efficacy and Safety of Novel Antiplatelets and Standard Therapy in Patients With Coronary Artery Disease. [PDF]

Cureus
Gangavarapu RR, Mahmud SA, Manandhar A, Sabir G, Abdelhady HA, Oumar Abakar A, Nassar ST.   +6 more
europepmc   +1 more source

Laparoscopic Cholecystectomy in a Patient with Low-Lying Costal Arch due to Ankylosing Spondylitis: A Case Report. [PDF]

Surg Case Rep
Fukami T, Minato H, Kosuga T, Arita T.
europepmc   +1 more source

Prasugrel Intermediate Metabolite Modulates Platelet Inhibition by Negatively Interfering With an Active Metabolite: An Ex Vivo, In Vitro, and In Silico Study. [PDF]

Arterioscler Thromb Vasc Biol
Minuz P, Giorgetti A, Meneguzzi A, Taus F, Ribeiro RP, Baldessari F, Gargiulo G, Gragnano F, Landi A, Castelli M, Gottardo R, Bortolotti F, Verlato G, Fava C, Cattaneo M, Tagliaro F, Valgimigli M.   +16 more
europepmc   +1 more source

Exploring the relationship of platelet aggregation function with efficacy and safety outcomes following the administration of prasugrel and clopidogrel in patients with thrombotic stroke: a post hoc analysis of PRASTRO pooled studies. [PDF]

J Thromb Thrombolysis
Kimura K, Kamouchi M, Matsumaru Y, Kimura T, Katsuro R, Hosokawa J, Kitazono T.   +6 more
europepmc   +1 more source